Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observing the progression of axial spondyloarthritis in Chinese patients

Official title: The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Run by China-Japan Friendship Hospital · NCT06844643 · Data updated 2026-11-12

This study looks at how axial spondyloarthritis changes over time in Chinese adults to better understand the disease and its effects.

More Axial Spondyloarthritis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2250 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedDecember 1, 2030
Study endsDecember 1, 2030
Registry record updatedApril 13, 2026
Trial IDNCT06844643 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are Chinese patients aged 18 years or older diagnosed with axial spondyloarthritis.

Probably not a fit

Patients with serious comorbid conditions or those who are pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to understand the disease progression of axial spondyloarthritis (axSpA) in Chinese patients aged 18 and older. Participants will be followed at 4-6 month intervals, with data collected at baseline and during follow-up visits. The primary outcomes include structural damage assessed through imaging techniques and disease activity measured by established scales. Secondary outcomes will focus on inflammatory markers and functional indices related to the disease.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the progression of axial spondyloarthritis, leading to improved management strategies for patients.

How similar studies have gone: While there have been studies on axial spondyloarthritis, this specific observational approach focusing on a Chinese cohort may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older
* Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria

Exclusion Criteria:

* Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to:

End-stage renal disease (eGFR \< 30 mL/min/1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment

* Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits.
* Pregnant or lactating women

Where it's running

  • China-Japan Friendship Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.